Michael Kelley, MD, is a Professor of Medicine at Duke University and Chief of Hematology and Oncology at the Durham VA Medical Center. As Executive Director of the National Oncology Program for the Department of Veterans Affairs, Dr. Kelley directs policy, program development, and clinical operations that affect the more than 42,000 Veterans diagnosed with cancer each year in the nation’s largest integrated health care system. Dr. Kelley’s clinical practice is focused on lung cancer and precision oncology and his academic interests are in molecular genetics, experimental therapeutics of targeted therapies, and outcomes research. Dr. Kelley is the author of more than 130 peer-reviewed primary research articles as well as reviews, book chapters, and numerous meeting abstracts. He is a recipient of the US Public Health Service’s Achievement Award, a member of the National Cancer Institute’s Clinical Trials and Translational Research Advisory Committee, and an ex officio member of the National Cancer Advisory Board.